ILSUNG IS CO., LTD. Logo

ILSUNG IS CO., LTD.

Develops and manufactures antibiotics, cardiovascular agents, and anesthetics.

003120 | KO

Overview

Corporate Details

ISIN(s):
KR7003120003
LEI:
Country:
South Korea
Address:
서울특별시 용산구 원효로84길 9, 서울특별시

Description

ILSUNG IS CO., LTD. is a pharmaceutical company specializing in the development and manufacturing of therapeutic products. The company's core portfolio is focused on antibiotics, cardiovascular agents, anesthetics, and contrast media. It is actively expanding its research and development into new therapeutic areas, including treatments for gastrointestinal (GI), central nervous system (CNS), and other cardiovascular (CV) conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-02-13 00:00
주요사항보고서(자기주식취득신탁계약체결결정)
Korean 25.7 KB
2023-02-10 00:00
주식등의대량보유상황보고서(약식)
Korean 65.1 KB
2023-02-09 00:00
주식등의대량보유상황보고서(일반)
Korean 231.4 KB
2023-02-09 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2023-02-06 00:00
[기재정정]최대주주등소유주식변동신고서
Korean 45.4 KB
2023-02-03 00:00
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 12.0 KB
2023-02-03 00:00
최대주주등소유주식변동신고서
Korean 42.3 KB
2023-01-26 00:00
[기재정정]유형자산취득결정
Korean 12.1 KB
2022-11-14 00:00
분기보고서 (2022.09)
Korean 728.5 KB
2022-09-30 00:00
[기재정정]유형자산취득결정
Korean 12.3 KB
2022-09-29 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2022-09-26 00:00
최대주주등소유주식변동신고서
Korean 42.3 KB
2022-09-23 00:00
조회공시요구(현저한시황변동)에대한답변(중요공시대상없음)
Korean 5.2 KB
2022-09-22 00:00
조회공시요구(현저한시황변동)
Korean 3.5 KB
2022-08-16 00:00
반기보고서 (2022.06)
Korean 727.6 KB

Automate Your Workflow. Get a real-time feed of all ILSUNG IS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ILSUNG IS CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ILSUNG IS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.